Recent Advances in Validating MDM2 as a Cancer Target
Elizabeth R. Rayburn, Ruiwen Zhang(Institute of Pharmacology)
Cited by 48
Related Papers
The MDM2-p53 pathway revisited
|Journal of Biomedical Research|2013|410
<i>In vitro</i> and <i>In vivo</i> Anticancer Activity of Novel Synthetic Makaluvamine Analogues
|Clinical Cancer Research|2009|65
Inulanolide A as a new dual inhibitor of NFAT1-MDM2 pathway for breast cancer therapy
|Oncotarget|2016|29
Identification of lineariifolianoid A as a novel dual NFAT1 and MDM2 inhibitor for human cancer therapy
|Journal of Biomedical Research|2016|23